Sonnenschein Nath & Rosenthal LLP - Susan DeSanti Discusses Competition Between Brand Name and Generic Prescription Drugs in Webinar

Event Date(s):	09-12-2007
Event Location(s):	Webinar
Presenter(s):	Susan DeSanti
Event Host(s):	The Center for Business Intelligence
Event Description:	Sonnenschein partner Susan DeSanti will speak during a webinar titled, "Competition with Authorized Generics: Fair or Foul?" on September 12. The event is presented by The Center for Business Intelligence. The Office of Management and Budget recently approved, without any changes, the Federal Trade Commission’s (FTC) proposed study of authorized generic pharmaceutical drugs. Through this study, the FTC will analyze aspects of competition between brand-name and generic drugs. This webinar will provide insight into the issues of interest and information that the FTC will subpoena for the FTC’s study, including how a company can protect its confidential business information if subpoenaed by the FTC. Ms. DeSanti also will discuss comparisons of the FTC's authorized generics study with past studies conducted by the FTC in 2002 and 2005. Click here for more information on the event.